Henoch-Schönlein Purpura with Adalimumab Therapy for Ulcerative Colitis: A Case Report and Review of the Literature

Tumor necrosis factor-α (TNFα) inhibitor therapy has signified an important milestone in the fight against many rheumatological disorders and inflammatory bowel disease (IBD). Cutaneous adverse events caused by this class of medications are well known but relatively uncommon. Most reactions are mild...

Descripción completa

Detalles Bibliográficos
Autores principales: LaConti, Joseph J., Donet, Jean A., Cho-Vega, Jeong Hee, Sussman, Daniel A., Ascherman, Dana, Deshpande, Amar R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978839/
https://www.ncbi.nlm.nih.gov/pubmed/27529048
http://dx.doi.org/10.1155/2016/2812980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978839/
https://www.ncbi.nlm.nih.gov/pubmed/27529048
http://dx.doi.org/10.1155/2016/2812980

Ejemplares similares